Live Breaking News & Updates on Treadwell Entertainment Group|Page 3

Stay updated with breaking news from Treadwell entertainment group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Treadwell Therapeutics: Treadwell Announces Initiation of Patient Dosing in TWT-203, a Phase 1b/2 study of TTK Inhibitor, CFI-402257, in Patients with ER+/Her2- Breast cancer

NEW YORK and HONG KONG, June 13, 2022 /PRNewswire/ Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for unmet needs in cancer, today announced the ....

United States , Salt Lake , Clinical Research , Salt Lake City , Principal Investigator , Michael Tusche , Recommended Phase ,